Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T G M van Erp; D P Hibar; J M Rasmussen; D C Glahn; G D Pearlson; O A Andreassen; I Agartz; L T Westlye; U K Haukvik; A M Dale; I Melle; C B Hartberg; O Gruber; B Kraemer; D Zilles; G Donohoe; S Kelly; C McDonald; D W Morris; D M Cannon; A Corvin; M W J Machielsen; L Koenders; L de Haan; D J Veltman; T D Satterthwaite; D H Wolf; R C Gur; R E Gur; S G Potkin; D H Mathalon; B A Mueller; A Preda; F Macciardi; S Ehrlich; E Walton; J Hass; V D Calhoun; H J Bockholt; S R Sponheim; J M Shoemaker; N E M van Haren; H E H Pol; R A Ophoff; R S Kahn; R Roiz-Santiañez; B Crespo-Facorro; L Wang; K I Alpert; E G Jönsson; R Dimitrova; C Bois; H C Whalley; A M McIntosh; S M Lawrie; R Hashimoto; P M Thompson; J A Turner

doi:10.1038/mp.2015.63

journal article Open Access Jun 02, 2015

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T G M van Erp D P Hibar J M Rasmussen D C Glahn G D Pearlson O A Andreassen I Agartz L T Westlye U K Haukvik A M Dale I Melle C B Hartberg O Gruber B Kraemer D Zilles G Donohoe S Kelly C McDonald D W Morris D M Cannon A Corvin M W J Machielsen L Koenders L de Haan D J Veltman T D Satterthwaite D H Wolf R C Gur R E Gur S G Potkin D H Mathalon B A Mueller A Preda

F Macciardi S Ehrlich E Walton J Hass V D Calhoun H J Bockholt S R Sponheim J M Shoemaker N E M van Haren H E H Pol R A Ophoff R S Kahn R Roiz-Santiañez B Crespo-Facorro L Wang

K I Alpert E G Jönsson R Dimitrova C Bois H C Whalley A M McIntosh S M Lawrie R Hashimoto P M Thompson J A Turner

Molecular Psychiatry Vol. 21 No. 4 pp. 547-553 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/mp.2015.63

Topics

No keywords indexed for this article. Browse by subject →

References

58

[1]

Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969–976. 10.1038/ng.940

[2]

Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371–1379. 10.1016/s0140-6736(12)62129-1

[3]

Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497–511. 10.1038/mp.2012.21

[4]

Ward KE, Friedman L, Wise A, Schulz SC . Meta-analysis of brain and cranial size in schizophrenia. Schizophr Res 1996; 22: 197–213. 10.1016/s0920-9964(96)00076-x

[5]

Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging

Michael D. Nelson, Andrew J. Saykin, Laura A. Flashman et al.

Archives of General Psychiatry 1998 10.1001/archpsyc.55.5.433

[6]

Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET . Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 16–25. 10.1176/ajp.157.1.16

[7]

Zakzanis KK, Poulin P, Hansen KT, Jolic D . Searching the schizophrenic brain for temporal lobe deficits: a systematic review and meta-analysis. Psychol Med 2000; 30: 491–504. 10.1017/s0033291799002172

[8]

Vita A, De Peri L, Silenzi C, Dieci M . Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006; 82: 75–88. 10.1016/j.schres.2005.11.004

[9]

Adriano F, Spoletini I, Caltagirone C, Spalletta G . Updated meta-analyses reveal thalamus volume reduction in patients with first-episode and chronic schizophrenia. Schizophr Res 2010; 123: 1–14. 10.1016/j.schres.2010.07.007

[10]

Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ . Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012; 36: 1342–1356. 10.1016/j.neubiorev.2011.12.015

[11]

Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects

Sander V. Haijma, Neeltje Van Haren, Wiepke Cahn et al.

Schizophrenia Bulletin 2012 10.1093/schbul/sbs118

[12]

Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, Tordesillas-Gutierrez D, Mata I, Rodriguez-Sanchez JM et al. Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers. Schizophr Res 2009; 115: 191–201. 10.1016/j.schres.2009.09.007

[13]

Pelayo-Teran JM, Perez-Iglesias R, Ramirez-Bonilla M, Gonzalez-Blanch C, Martinez-Garcia O, Pardo-Garcia G et al. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry 2008; 2: 178–187. 10.1111/j.1751-7893.2008.00074.x

[14]

Machielsen MW . Schizophrenia and Comorbid Cannabis Use Disorders. Ph.D. Thesis University of Amsterdam: Amsterdam, Netherlands, 2014.

[15]

McIntosh AM, Job DE, Moorhead TW, Harrison LK, Forrester K, Lawrie SM et al. Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry 2004; 56: 544–552. 10.1016/j.biopsych.2004.07.020

[16]

Gollub RL, Shoemaker JM, King MD, White T, Ehrlich S, Sponheim SR et al. The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics 2013; 11: 367–388. 10.1007/s12021-013-9184-3

[17]

Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG et al. Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 2002; 159: 244–250. 10.1176/appi.ajp.159.2.244

[18]

Boos HB, Cahn W, van Haren NE, Derks EM, Brouwer RM, Schnack HG et al. Focal and global brain measurements in siblings of patients with schizophrenia. Schizophr Bull 2012; 38: 814–825. 10.1093/schbul/sbq147

[19]

Trost S, Platz B, Usher J, Scherk H, Wobrock T, Ekawardhani S et al. DISC1 (disrupted-in-schizophrenia 1) is associated with cortical grey matter volumes in the human brain: a voxel-based morphometry (VBM) study. J Psychiatr Res 2013; 47: 188–196. 10.1016/j.jpsychires.2012.10.006

[20]

Gruber O . Neuroimaging markers: their role for differential diagnosis and therapeutic decisions in personalized psychiatry. Nervenarzt 2011; 82: 1404, 1406, 1408, passim.

[21]

Wang L, Kogan A, Cobia D, Alpert K, Kolasny A, Miller MI et al. Northwestern University Schizophrenia Data and Software Tool (NUSDAST). Front Neuroinform 2013; 7: 25.

[22]

Whole Brain Segmentation

Bruce Fischl, David H. Salat, Evelina Busa et al.

Neuron 2002 10.1016/s0896-6273(02)00569-x

[23]

FreeSurfer

Bruce Fischl

NeuroImage 2012 10.1016/j.neuroimage.2012.01.021

[24]

Effect size, confidence interval and statistical significance: a practical guide for biologists

Shinichi Nakagawa, Innes C. Cuthill

Biological Reviews 2007 10.1111/j.1469-185x.2007.00027.x

[25]

Erdefelder E, Faul F, Buchner A . GPOWER: a general power analysis porgram. Behav Res Methods Instrum Comput 1996; 28: 1–11. 10.3758/bf03203630

[26]

Goltz HH, Smith ML . Yule–Simpson's paradox in research. Pract Assess Res Eval 2010; 15: 1–9.

[27]

Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC . Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155: 1711–1717. 10.1176/ajp.155.12.1711

[28]

Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 2007; 154: 199–208. 10.1016/j.pscychresns.2006.10.002

[29]

Hulshoff Pol HE, Kahn RS . What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 2008; 34: 354–366. 10.1093/schbul/sbm168

[30]

Li M, Chen Z, Deng W, He Z, Wang Q, Jiang L et al. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. Psychol Med 2011; 42: 1475–1483. 10.1017/s0033291711002157

[31]

Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M et al. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. J Clin Psychopharmacol 2011; 31: 146–153. 10.1097/jcp.0b013e31820e3f58

[32]

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V . Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128–137. 10.1001/archgenpsychiatry.2010.199

[33]

Hutcheson NL, Clark DG, Bolding MS, White DM, Lahti AC . Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Res 2014; 221: 6–12. 10.1016/j.pscychresns.2013.10.002

[34]

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S . Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 2013; 37: 1680–1691. 10.1016/j.neubiorev.2013.06.001

[35]

Oertel-Knochel V, Knochel C, Matura S, Rotarska-Jagiela A, Magerkurth J, Prvulovic D et al. Cortical-basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives. Schizophr Res 2012; 138: 120–127. 10.1016/j.schres.2012.02.029

[36]

Yang Y, Nuechterlein KH, Phillips OR, Gutman B, Kurth F, Dinov I et al. Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study. Hum Brain Mapp 2012; 33: 2081–2091. 10.1002/hbm.21349

[37]

Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF et al. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 2008; 63: 465–474. 10.1016/j.biopsych.2007.05.027

[38]

Dougherty MK, Gu H, Bizzell J, Ramsey S, Gerig G, Perkins DO et al. Differences in subcortical structures in young adolescents at familial risk for schizophrenia: a preliminary study. Psychiatry Res 2012; 204: 68–74. 10.1016/j.pscychresns.2012.04.016

[39]

Koolschijn PC, van Haren NE, Cahn W, Schnack HG, Janssen J, Klumpers F et al. Hippocampal volume change in schizophrenia. J Clin Psychiatry 2010; 71: 737–744. 10.4088/jcp.08m04574yel

[40]

Newton SS, Duman RS . Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 2007; 21: 715–725. 10.2165/00023210-200721090-00002

[41]

Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS . Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev 2013; 37: 2418–2423. 10.1016/j.neubiorev.2012.09.006

[42]

Pearlson GD, Garbacz DJ, Breakey WR, Ahn HS, DePaulo JR . Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Res 1984; 12: 1–9. 10.1016/0165-1781(84)90133-1

[43]

Penttila M, Jaaskelainen E, Haapea M, Tanskanen P, Veijola J, Ridler K et al. Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophr Res 2010; 123: 145–152. 10.1016/j.schres.2010.08.016

[44]

Brouwer RM, Hulshoff Pol HE, Schnack HG . Segmentation of MRI brain scans using non-uniform partial volume densities. Neuroimage 2010; 49: 467–477. 10.1016/j.neuroimage.2009.07.041

[45]

Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009; 46: 177–192. 10.1016/j.neuroimage.2009.02.010

[46]

Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE et al. Structural magnetic resonance imaging in bipolar disorder: An International Collaborative Mega-analysis of Individual Adult Patient Data. Biol Psychiatry 2011; 69: 326–335. 10.1016/j.biopsych.2010.08.029

[47]

Hibar DP Robust subcortical volumetric reductions in bipolar disorder: findings from the ENIGMA bipolar disorder working group including 1,745 cases and 2,613 controls. Proc Natl Acad Sci USA (submitted).

[48]

Schmaal L Subcortical brain volume abnormalities in major depressive disorder: prospective meta-analytic findings from the ENIGMA Major Depressive Disorder Working Group including 1,808 cases and 7,223 controls. Proc Natl Acad Sci USA (submitted).

[49]

Gronenschild EH, Habets P, Jacobs HI, Mengelers R, Rozendaal N, van Os J et al. The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements. PLoS One 2012; 7: e38234. 10.1371/journal.pone.0038234

[50]

Van Erp TG, Saleh PA, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T et al. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 2002; 159: 1514–1520. 10.1176/appi.ajp.159.9.1514

Showing 50 of 58 references

Cited By

857

Cell type-specific transcriptional features associated with gray matter volume alterations in schizophrenia with predominantly negative symptoms

Xinping Kuai, Suzhen Zhang · 2026

Asian Journal of Psychiatry

Untangling Depression in Schizophrenia: The Role of Disorganized and Obsessive-Compulsive Symptoms and the Duration of Untreated Psychosis

Georgi Panov, Silvana Dyulgerova · 2024

Biomedicines

Schizophrenia genomics: genetic complexity and functional insights

Patrick F. Sullivan, Shuyang Yao · 2024

Nature Reviews Neuroscience

Few-Shot Domain-Adaptive Anomaly Detection for Cross-Site Brain Images

Jianpo Su, Hui Shen · 2024

IEEE Transactions on Pattern Analys...

Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders

Ye Ella Tian, Maria A. Di Biase · 2023

JAMA Psychiatry

A systematic review of neuroimaging studies of clozapine-resistant schizophrenia

Tiffanie Sze Wing Pang, Johnny Siu Wah Chun · 2023

Schizophrenia

Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings

Eun‐Jin Cheon, Carrie E. Bearden · 2022

Psychiatry and Clinical Neuroscienc...

Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis

Lucy D. Vanes, Robin M. Murray · 2022

Schizophrenia Research

ECT-induced cognitive side effects are associated with hippocampal enlargement

Miklos Argyelan, Todd Lencz · 2021

Translational Psychiatry

Quantifying Retinal Microvascular Morphology in Schizophrenia Using Swept-Source Optical Coherence Tomography Angiography

Deepthi Bannai, Iniya Adhan · 2021

Schizophrenia Bulletin

Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years

Danai Dima, Amirhossein Modabbernia · 2021

Human Brain Mapping

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group

Laura K. M. Han, Richard Dinga · 2020

Molecular Psychiatry

In vivo hippocampal subfield volumes in bipolar disorder—A mega‐analysis from The Enhancing Neuro Imaging Genetics through Meta‐Analysis Bipolar Disorder Working Group

Unn K. Haukvik, Tiril P. Gurholt · 2020

Human Brain Mapping

The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology

Olav B. Smeland, Oleksandr Frei · 2020

Nature Reviews Neurology

JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps

Juergen Dukart, Stefan Holiga · 2020

Human Brain Mapping

Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning

Ganesh B Chand, Dominic B Dwyer · 2020

Brain

Hippocampal volume and hippocampal neuron density, number and size in schizophrenia: a systematic review and meta-analysis of postmortem studies

Maxwell J. Roeske, Christine Konradi · 2020

Molecular Psychiatry

ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries

Paul M. Thompson, Neda Jahanshad · 2020

Translational Psychiatry

Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

Joaquim Radua, Eduard Vieta · 2020

NeuroImage

Deep rTMS Mitigates Behavioral and Neuropathologic Anomalies in Cuprizone-Exposed Mice Through Reducing Microglial Proinflammatory Cytokines

Liu Yang, Yawen Su · 2020

Frontiers in Integrative Neuroscien...

Metrics

857

Citations

58

References

Details

Published: Jun 02, 2015
Vol/Issue: 21(4)
Pages: 547-553
License: View

Authors

Chiron Corporation, Emeryville, CA 94608.

Cite This Article

T G M van Erp, D P Hibar, J M Rasmussen, et al. (2015). Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry, 21(4), 547-553. https://doi.org/10.1038/mp.2015.63

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

You May Also Like